P

Inventor

THOEGERSEN HENNING

DK29 patents
⚠️ This page may combine multiple inventors who share the name “THOEGERSEN HENNING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVO NORDISK AS

23 patents
US5922770AJul 13, 1999

Compounds with growth hormone releasing properties

NOVO NORDISK AS50 citations96
US6875760B2Apr 5, 2005

Glucagon antagonists/inverse agonists

NOVO NORDISK AS56 citations93
US6274584B1Aug 14, 2001

Compounds with growth hormone releasing properties

NOVO NORDISK AS30 citations92
US6127354AOct 3, 2000

Compounds with growth hormone releasing properties

NOVO NORDISK AS20 citations92
US5998375ADec 7, 1999

Nociceptin analogues

NOVO NORDISK AS44 citations90
US9409966B2Aug 9, 2016

Glucagon-like peptide-1 derivatives and their pharmaceutical use

NOVO NORDISK AS6 citations83
US9067977B2Jun 30, 2015

Peptides derivatized with A-B-C-D- and their therapeutical use

NOVO NORDISK AS18 citations83
US8541368B2Sep 24, 2013

Glucagon analogues

NOVO NORDISK AS6 citations82
US9272019B2Mar 1, 2016

MIC-1 fusion proteins and uses thereof

NOVO NORDISK AS11 citations81
US10604555B2Mar 31, 2020

GIP derivatives and uses thereof

NOVO NORDISK AS5 citations79
US5854211ADec 29, 1998

Compounds with growth hormone releasing properties

NOVO NORDISK AS15 citations72
US10398782B2Sep 3, 2019

MIC-1 compounds and uses thereof

NOVO NORDISK AS5 citations70
US11186595B2Nov 30, 2021

Glucose-sensitive albumin-binding derivatives

NOVO NORDISK AS3 citations68
US9956264B2May 1, 2018

MIC-1 fusion proteins and uses thereof

NOVO NORDISK AS4 citations64
US9029325B2May 12, 2015

Amylin analogues and pharmaceutical compositions thereof

NOVO NORDISK AS2 citations62
US9486505B2Nov 8, 2016

Glucagon analogues

NOVO NORDISK AS2 citations61
US9486506B2Nov 8, 2016

Glucagon analogues

NOVO NORDISK AS1 citations61
US12006344B2Jun 11, 2024

MIC-1 compounds and use thereof

NOVO NORDISK AS0 citations59
US10822385B2Nov 3, 2020

EGF(A) analogues with fatty acid substituents

NOVO NORDISK AS1 citations59
US11767332B2Sep 26, 2023

Glucose-sensitive albumin-binding derivatives

NOVO NORDISK AS1 citations58
US11633459B2Apr 25, 2023

GIP derivatives and uses thereof

NOVO NORDISK AS1 citations58
US12227528B2Feb 18, 2025

Glucose-sensitive albumin-binding derivatives

NOVO NORDISK AS0 citations57
US9988430B2Jun 5, 2018

Stable GLP-1 based GLP-1/glucagon receptor co-agonists

NOVO NORDISK AS1 citations49

SCHAEFFER LAUGE

3 patents

NORO NORDISK AS

1 patent

KOFOED JACOB

1 patent

TAGMOSE TINA MOELLER

1 patent